249 related articles for article (PubMed ID: 23494009)
1. Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets.
Stevic I; Chan HH; Chander A; Berry LR; Chan AK
Thromb Haemost; 2013 Jun; 109(6):1016-24. PubMed ID: 23494009
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
Stevic I; Berry LR; Chan AK
J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
[TBL] [Abstract][Full Text] [Related]
3. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex.
Stevic I; Chan HH; Berry LR; Chander A; Chan AK
J Biochem; 2013 Jan; 153(1):103-10. PubMed ID: 23100269
[TBL] [Abstract][Full Text] [Related]
5. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
7. Analysis of inhibition rate enhancement by covalent linkage of antithrombin to heparin as a potential predictor of reaction mechanism.
Patel S; Berry LR; Chan AK
J Biochem; 2007 Jan; 141(1):25-35. PubMed ID: 17167048
[TBL] [Abstract][Full Text] [Related]
8. Covalent antithrombin-heparin complexes.
Patel S; Berry LR; Chan AK
Thromb Res; 2007; 120(2):151-60. PubMed ID: 16978685
[TBL] [Abstract][Full Text] [Related]
9. Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.
Wood JP; Baumann Kreuziger LM; Desai UR; Mast AE
Br J Haematol; 2016 Oct; 175(1):123-32. PubMed ID: 27301751
[TBL] [Abstract][Full Text] [Related]
10. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
Koklic T; Chattopadhyay R; Majumder R; Lentz BR
Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
[TBL] [Abstract][Full Text] [Related]
11. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
Chan AK; Berry LR; Monagle PT; Andrew M
Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
[TBL] [Abstract][Full Text] [Related]
12. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
13. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
14. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
Chang GMT; Atkinson HM; Berry LR; Chan AKC
Blood Coagul Fibrinolysis; 2017 Sep; 28(6):431-437. PubMed ID: 27898513
[TBL] [Abstract][Full Text] [Related]
16. Dual effect of Platelet Factor 4 on the activities of Factor Xa.
Fiore MM; Mackie IJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):1072-5. PubMed ID: 19150337
[TBL] [Abstract][Full Text] [Related]
17. Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex.
Brufatto N; Ward A; Nesheim ME
J Thromb Haemost; 2003 Jun; 1(6):1258-63. PubMed ID: 12871328
[TBL] [Abstract][Full Text] [Related]
18. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
19. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
Harenberg J; Giese C; Hagedorn A; Traeger I; Fenyvesi T
Semin Thromb Hemost; 2007 Jul; 33(5):503-7. PubMed ID: 17629847
[TBL] [Abstract][Full Text] [Related]
20. Effects of fondaparinux and a direct factor Xa inhibitor TAK-442 on platelet-associated prothrombinase in the balloon-injured artery of rats.
Konishi N; Hiroe K; Kawamura M
J Cardiovasc Pharmacol; 2011 Feb; 57(2):201-6. PubMed ID: 21052010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
